By Rishika Sadam MUMBAI, Feb 25 (Reuters) - Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according ...

Both ADOS-2 training workshops provide experienced autism professionals with introductory training on the use of the ADOS-2 in clinical settings across ages, developmental levels, and language skills.